It is widely accepted that the CXCR4/CXCL12 axis underlies the decreased chemosensitivity and disease progression, by directing CXCR4-expressing tumor cells through concentration gradients of CXCL12 to reside in protective niche (such as BM and lymph nodes). The gene discussed is CXCR4; the disease is neoplasm.